NDC11 72374010101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72374-0101-01 | 72374-0101 |
| 72374-0101-1 | 72374-0101 |
| 72374-101-01 | 72374-101 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NYPOZI txid | FILGRASTIM-TXID | Tanvex BioPharma USA, Inc. | 89092bb8-6a20-e23e-e053-2a95a90aa750 | 2026-01-15 | Warnings, Adverse reactions | 72374-101-01 72374-101 72374010101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.